LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 15 of 15: Calculated dose-response metrics. - Dataset (ID:20252)
Small Molecules Studied
Download: Excel (XLSX), Comma-separated (CSV), Images (Zip file)
| HMS LINCS ID | Name | Alternative Names | LINCS ID | Structure Image | PubChem CID |
|---|---|---|---|---|---|
| 10172-1 | GSK1059615 | LSM-1173 |  | 71317162 | |
| 10177-1 | Brivanib | BMS-540215 | LSM-1178 |  | 11451527 |
| 10180-1 | CHIR-99021 | CT99021; KIN001-157 | LSM-1181 |  | 9956119 |
| 10182-1 | Linifanib | ABT-869; AL-39324 | LSM-1183 |  | 11485656 |
| 10190-1 | PIK-93 | LSM-1191 |  | 6852167 | |
| 10479-1 | Mitoxantrone | CL 232325; CL-232325; DHAQ; Novantron; Novantrone | LSM-2481 |  | 4212 |
| 10100-1 | JNK-9L | KIN001-204 | LSM-36386 |  | 25222038 |
| 10232-1 | Dactolisib | BEZ235; NVP-BEZ235 | LSM-4255 |  | 11977753 |
| 10233-1 | Alpelisib | BYL719 | LSM-4256 |  | 56649450 |
| 10234-1 | GDC-0980 | RG7422 | LSM-4257 |  | 66694608 |
| 10046-1 | SB590885 | LSM-42746 |  | 53239990 | |
| 10010-1 | CP724714 | LSM-42777 |  | 53401057 | |
| 10018-1 | Neratinib | HKI-272 | LSM-42778 |  | 53398697 |
| 10031-1 | KIN001-043 | LSM-42780 |  | 24906282 | |
| 10108-1 | Geldanamycin | LSM-42789 |  | 644250 | |
| 10119-1 | SU11274 | PKI-SU11274 | LSM-42791 |  | 53396327 |
| 10125-1 | PHA-665752 | LSM-42793 |  | 66596670 | |
| 10133-1 | Afatinib | BIBW-2992 | LSM-43226 |  | 57519523 |
| 10017-1 | HG-6-64-01 | KIN001-206 | LSM-43248 |  | |
| 10091-1 | XMD16-144 | LSM-43287 |  | ||
| 10480-1 | Radicicol | Monorden | LSM-43318 |  | 6323491 |
| 10039-1 | WH-4-025 | LSM-44937 | |||
| 10122-1 | NVP-AEW541 | AEW541 | LSM-44953 |  | 11476171 |
| 10016-1 | HG-5-88-01 | LSM-5245 |  | 25226117 | |
| 10082-1 | WZ-4-145 | LSM-5545 |  |